Medivation is engaged in development and commercialization of novel small molecule drugs to treat serious diseases.
Business Model:
Revenue: $996.6M
Employees: 501-1,000
Medivation was acquired by
Pfizer.
The acquisition happend on 2016-08-22.
Details of the transaction were not public
Address: 525 Market St
City: San Francisco
State: CA
Zip: 94105
Country: US
Medivation is engaged in development and commercialization of novel small molecule drugs to treat serious diseases.
Contact Phone:
+14155433470
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/19/2007
Ticker Symbol:
MDVN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2008 | Post-IPO Equity | 1 | - |
Plough Penny Partners Plough Penny Partners |
3/2008 | Post-IPO Equity | 1 | - |
Plough Penny Partners Plough Penny Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|